Repurposing Ivermectin for PKDL Treatment
NCT06251739
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Post-kala-azar Dermal Leishmaniasis
Interventions
DRUG:
Ivermectin 6 Mg Oral Tablet
DRUG:
Miltefosine Oral Capsule
Sponsor
International Centre for Diarrhoeal Disease Research, Bangladesh